Search results
Here's How Moderna Plans to Win in the Post-Emergency COVID Vaccine Market
Motley Fool· 12 months agoHigh demand for coronavirus vaccines earlier in the pandemic pushed Moderna's (NASDAQ: MRNA)...
2 Reasons Moderna Could Dominate the Long-Term Vaccine Market
Motley Fool· 2 years agoThere's no doubt about it: Moderna (NASDAQ: MRNA) today is a leader in the coronavirus vaccine...
Moderna CEO faces Sen. Sanders in COVID-19 vaccine pricing hearing Wednesday
Yahoo Finance via AOL· 1 year agoModerna (MRNA) CEO Stéphane Bancel will join a panel in front of the Senate Health, Education, Labor...
Moderna's bivalent vaccine to arrive end-Sep, Pfizer's being evaluated: Ong Ye Kung
Yahoo News Singapore· 2 years agoData shows that the Moderna bivalent vaccine can protect well against the original COVID-19 strain...
3 Things the Smartest Investors Know About This Beaten-Down Stock
Motley Fool· 2 years agoMost people consider Moderna (NASDAQ: MRNA) a coronavirus vaccine stock. And for good reason. The...
Moderna accuses Pfizer/BioNTech of patent infringement over the tech behind its COVID vaccine
WFXT via Yahoo News· 2 years agoA legal battle is brewing between makers of vaccines against COVID-19. Cambridge-based Moderna is...
Hitting the Books: How Moderna dialed-in its vaccine to fight COVID's variants
Engadget· 2 years agoIn "The Messenger," veteran reporter Peter Loftus takes readers through the harrowing days of 2020...
Moderna Stock: Bull vs. Bear
Motley Fool via Yahoo Finance· 1 month agoModerna (NASDAQ: MRNA) shot to stardom in the early days of the pandemic as it brought its coronavirus vaccine from drawing board to commercialization in...
Moderna sues Pfizer for allegedly copying its COVID-19 vaccine technology
The Week via Yahoo News· 2 years agoModerna and Pfizer vaccines Marcos del Mazo/LightRocket via Getty Images Moderna is taking Pfizer...
Moderna Just Took a Step Closer to Its Product Launch Goal. Is the Stock a Buy?
Motley Fool via Yahoo Finance· 4 months agoModerna (NASDAQ: MRNA) today is known for its one and only product: the coronavirus vaccine now...